First Data on Remdesivir: Two-Thirds of COVID-19 Patients Improved

]]>(MedPage Today) -- About two-thirds of severe COVID-19 coronavirus patients treated with the investigational antiviral agent remdesivir showed clinical improvement, researchers found.But by the same token, about one-third did not--including...